The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI
Open accessAbstract
We investigated the ability of targeted immunomicelles to detect and assess macrophages in atherosclerotic plaque using MRI in vivo . There is a large clinical need for a noninvasive tool to assess atherosclerosis from a molecular and cellular standpoint. Macrophages play a central role in atherosclerosis and are associated with plaques vulnerable to rupture. Therefore, macrophage scavenger receptor (MSR) was chosen as a target for molecular MRI. MSR-targeted immunomicelles, micelles, and gadolinium–diethyltriaminepentaacetic acid (DTPA) were tested in ApoE−/− and WT mice by using in vivo MRI. Confocal laser-scanning microscopy colocalization, macrophage immunostaining and MRI correlation, competitive inhibition, and various other analyses were performed. In vivo MRI revealed that at 24 h postinjection, immunomicelles provided a 79% increase in signal intensity of atherosclerotic aortas in ApoE−/− mice compared with only 34% using untargeted micelles and no enhancement using gadolinium–DTPA. Confocal laser-scanning microscopy revealed colocalization between fluorescent immunomicelles and macrophages in plaques. There was a strong correlation between macrophage content in atherosclerotic plaques and the matched in vivo MRI results as measured by the percent normalized enhancement ratio. Monoclonal antibodies to MSR were able to significantly hinder immunomicelles from providing contrast enhancement of atherosclerotic vessels in vivo . Immunomicelles provided excellent validated in vivo enhancement of atherosclerotic plaques. The enhancement seen is related to the macrophage content of the atherosclerotic vessel areas imaged. Immunomicelles may aid in the detection of high macrophage content associated with plaques vulnerable to rupture.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, macrophages and oxidized LDL have been targeted using immunomicelles43,134, and apoptosis has been studied using annexin A5-functionalized nanoparticles135.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [134]
Citations
Cites
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492
Heart Disease and Stroke Statistics—2006 Update
Writing Group Members, Thom, T., Haase, N., Rosamond, W. D., Howard, V. J., Rumsfeld, J. S., Manolio, T. A., Zheng, Z., Flegal, K. M., O’Donnell, C. J., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,453
From Vulnerable Plaque to Vulnerable Patient
Naghavi, M., Libby, P., Falk, E., Casscells, S. W., Litovsky, S. H., Rumberger, J. A., Badimón, J. J., Stefanadis, C., Moreno, P., Pasterkamp, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000087481.55887.c9 · Cited by 2,679
Self-citationGoldstein, J. L., Ho, Y. K., Basu, S. K., & Brown, M. S. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.333 · Cited by 2,447
From Vulnerable Plaque to Vulnerable Patient
Naghavi, M., Libby, P., Falk, E., Casscells, S. W., Litovsky, S. H., Rumberger, J. A., Badimón, J. J., Stefanadis, C., Moreno, P., Pasterkamp, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000087480.94275.97 · Cited by 2,298
Self-citationPlump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Sudden Cardiac Death in the United States, 1989 to 1998
Zheng, Z., Croft, J. B., Giles, W. H., & Mensah, G. A. (2001) · Circulation · doi:10.1161/hc4301.098254 · Cited by 1,597
Current Concepts of the Pathogenesis of the Acute Coronary Syndromes
Libby, P. (2001) · Circulation · doi:10.1161/01.cir.104.3.365 · Cited by 1,575
Intraplaque Hemorrhage and Progression of Coronary Atheroma
Kolodgie, F. D., Gold, H. K., BURKE, A. P., Fowler, D. R., Kruth, H. S., Weber, D. K., Farb, A. A., Guerrero, L. J., Hayase, M., Kutys, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035655 · Cited by 1,491
Research works printed but not linked: 1
- 10.1146/annurev.bi.63.070194.003125 · DOI
Cited by
Sorted by citations
Chen, L., Tredget, E. E., Wu, P. Y. G., & Wu, Y. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001886 · Cited by 1,610
Barua, S., & Mitragotri, S. (2014) · Nano Today · doi:10.1016/j.nantod.2014.04.008 · Cited by 1,288
A Molecular Imaging Primer: Modalities, Imaging Agents, and Applications
James, M. L., & Gambhir, S. S. (2012) · Physiological Reviews · doi:10.1152/physrev.00049.2010 · Cited by 1,199
Imaging macrophages with nanoparticles
Weissleder, R., Nahrendorf, M., & Pittet, M. J. (2014) · Nature Materials · doi:10.1038/nmat3780 · Cited by 809
The macrophage: Past, present and future
Gordon, S. (2007) · European Journal of Immunology · doi:10.1002/eji.200737638 · Cited by 640
Imaging of atherosclerotic cardiovascular disease
Sanz, J., & Fayad, Z. A. (2008) · Nature · doi:10.1038/nature06803 · Cited by 558
Self-citationMacrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis
Chen, W., Schilperoort, M., Cao, Y., Shi, J., Tabas, I. A., & Tao, W. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00629-x · Cited by 544
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
Lobatto, M. E., Fuster, V., Fayad, Z. A., & Mulder, W. J. M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3578 · Cited by 423
Self-citationWei, X., Man, Y. M., Dehaini, D., Su, Y., Kroll, A. V., Zhou, J., Gao, W., Fang, R. H., Chien, S., & Zhang, L. (2017) · ACS Nano · doi:10.1021/acsnano.7b07720 · Cited by 336
Gao, W. Z., Sun, Y., Cai, M., Zhao, Y., Cao, W., Liu, Z., Cui, G., & Tang, B. (2018) · Nature Communications · doi:10.1038/s41467-017-02657-z · Cited by 333
Nanotechnology in Medical Imaging
Cormode, D. P., Skajaa, T., Fayad, Z. A., & Mulder, W. J. M. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.165506 · Cited by 284
Self-citationWykrzykowska, J. J., Lehman, S., Williams, G., Parker, J. A., Palmer, M. R., Varkey, S. C., Kolodny, G. M., & Laham, R. J. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.055616 · Cited by 263
The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges
Greaves, D. R., & Gordon, S. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800066-jlr200 · Cited by 248
Macrophages in diabetic nephropathy in patients with type 2 diabetes
Klessens, C. Q. F., Zandbergen, M., Wolterbeek, R., Bruijn, J. A., Rabelink, T. J., Bajema, I. M., & IJpelaar, D. H. T. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw260 · Cited by 240
Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases
Godin, B., Sakamoto, J. H., Serda, R. E., Grattoni, A., Bouamrani, A., & Mauro Ferrari, B. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.01.003 · Cited by 236
Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications
Sosnovik, D. E., Nahrendorf, M., & Weissleder, R. (2008) · Basic Research in Cardiology · doi:10.1007/s00395-008-0710-7 · Cited by 229
Molecular Imaging of Cardiovascular Disease
Jaffer, F. A., Libby, P., & Weissleder, R. (2007) · Circulation · doi:10.1161/circulationaha.106.647164 · Cited by 220
Modified natural nanoparticles as contrast agents for medical imaging
Cormode, D. P., Jarzyna, P. A., Mulder, W. J. M., & Fayad, Z. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.005 · Cited by 200
Self-citationOptical and Multimodality Molecular Imaging
Jaffer, F. A., Libby, P., & Weissleder, R. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.165530 · Cited by 186
Briley-Saebo, K. C., Shaw, P. X., Mulder, W. J. M., Choi, S., Vucic, E., Aguinaldo, J. G. S., Witztum, J. L., Fuster, V., Tsimikas, S., & Fayad, Z. A. (2008) · Circulation · doi:10.1161/circulationaha.107.757120 · Cited by 184
Self-citationMagnetic and Fluorescent Nanoparticles for Multimodality Imaging
Mulder, W. J. M., Griffioen, A. W., Strijkers, G. J., Cormode, D. P., Nicolay, K., & Fayad, Z. A. (2007) · Nanomedicine · doi:10.2217/17435889.2.3.307 · Cited by 182
Self-citationMultimodal nonlinear optical microscopy
Yue, S., Slipchenko, M. N., & Cheng, J. (2011) · Laser & Photonics Review · doi:10.1002/lpor.201000027 · Cited by 187
MRI of carotid atherosclerosis: clinical implications and future directions
Underhill, H. R., Hatsukami, T. S., Fayad, Z. A., Fuster, V., & Yuan, C. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.246 · Cited by 175
Self-citationMultimodality Cardiovascular Molecular Imaging, Part I
Sinusas, A. J., Bengel, F. M., Nahrendorf, M., Epstein, F. H., Wu, J. C., Villanueva, F. S., Fayad, Z. A., & Gropler, R. J. (2008) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.108.824359 · Cited by 175
Self-citationLobatto, M. E., Fayad, Z. A., Silvera, S., Vucic, E., Calcagno, C., Mani, V., Dickson, S. D., Nicolay, K., Banciu, M., Schiffelers, R. M., et al. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100309y · Cited by 170
Self-citationHyaluronic Acid Immobilized Magnetic Nanoparticles for Active Targeting and Imaging of Macrophages
Kamat, M. N., El‐Boubbou, K., Zhu, D. C., Lansdell, T. A., Lu, X., Li, W., & Huang, X. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100354m · Cited by 169
Bruckman, M. A., Jiang, K., Simpson, E. J., Randolph, L. N., Luyt, L. G., Yu, X., & Steinmetz, N. F. (2014) · Nano Letters · doi:10.1021/nl404816m · Cited by 165
Cardiovascular Molecular Imaging
Chen, I. Y., & Wu, J. C. (2011) · Circulation · doi:10.1161/circulationaha.109.916338 · Cited by 164
Paramagnetic, Silicon Quantum Dots for Magnetic Resonance and Two-Photon Imaging of Macrophages
Tu, C., Ma, X., Pantazis, P., Kauzlarich, S. M., & Louie, A. Y. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909303g · Cited by 159
Lancelot, E., Amirbekian, V., Brigger, I., Raynaud, J.-S., Ballet, S., David, C., Rousseaux, O., Greneur, S. L., Port, M., Lijnen, H. R., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.149666 · Cited by 151
Self-citationChhour, P., Naha, P. C., O'Neill, S. M., Litt, H. I., Reilly, M. P., Ferrari, V. A., & Cormode, D. P. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.009 · Cited by 142
Qin, J., Peng, Z., Li, B., Ye, K., Zhang, Y., Yuan, F., Yang, X., Huang, L., Hu, J., & Lu, X. (2015) · Nanoscale · doi:10.1039/c5nr02521d · Cited by 141
Supramolecular aggregates containing lipophilic Gd(III) complexes as contrast agents in MRI
Accardo, A., Tesauro, D., Aloj, L., Pedone, C., & Morelli, G. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.01.015 · Cited by 136
Multimodality Cardiovascular Molecular Imaging, Part II
Nahrendorf, M., Sosnovik, D. E., French, B. A., Świrski, F. K., Bengel, F. M., Sadeghi, M. M., Lindner, J. R., Wu, J. C., Kraitchman, D. L., Fayad, Z. A., et al. (2009) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.108.839092 · Cited by 138
Self-citationHeterogeneous In Vivo Behavior of Monocyte Subsets in Atherosclerosis
Świrski, F. K., Weissleder, R., & Pittet, M. J. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.180521 · Cited by 139
Detection and treatment of atherosclerosis using nanoparticles
Zhang, J., Zu, Y., Dhanasekara, C. S., Li, J., Wu, D., Fan, Z., & Wang, S. F. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1412 · Cited by 132
Lymphocytes and the Adventitial Immune Response in Atherosclerosis
Campbell, K. A., Lipinski, M. J., Doran, A. C., Skaflen, M. D., Fuster, V., & McNamara, C. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.263186 · Cited by 130
Self-citationLi, D., Patel, A. R., Klibanov, A. L., Kramer, C. M., Ruiz, M., Kang, B., Mehta, J. L., Beller, G., Glover, D. K., & Meyer, C. H. (2010) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.109.896654 · Cited by 128
Kim, H., Kim, Y., Kim, I.-H., Kim, K., & Choi, Y. (2014) · Theranostics · doi:10.7150/thno.7101 · Cited by 127
Metal containing nanosized systems for MR-Molecular Imaging applications
Castelli, D. D., Gianolio, E., Crich, S. G., Terreno, E., & Aime, S. (2008) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2008.05.006 · Cited by 126
Phinikaridou, A., Andía, M. E., Protti, A., Indermuehle, A., Shah, A. M., Smith, A., Warley, A., & Botnar, R. M. (2012) · Circulation · doi:10.1161/circulationaha.112.092098 · Cited by 126
Nutrition and Cardiovascular Disease
Getz, G. S., & Reardon, C. A. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.155853 · Cited by 123
Molecular Imaging of Atherosclerosis for Improving Diagnostic and Therapeutic Development
Quillard, T., & Libby, P. (2012) · Circulation Research · doi:10.1161/circresaha.112.268144 · Cited by 126
Nanomedicine approaches in vascular disease: a review
Gupta, A. S. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.04.001 · Cited by 123
Inflammation Imaging in Atherosclerosis
Rudd, J. H. F., Hyafil, F., & Fayad, Z. A. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.165563 · Cited by 120
Self-citationQiao, R., Qiao, H., Zhang, Y., Wang, Y., Chi, C., Tian, J., Zhang, L., Cao, F., & Gao, M. (2017) · ACS Nano · doi:10.1021/acsnano.6b07842 · Cited by 120
Korosoglou, G., Weiss, R. G., Kedziorek, D., Walczak, P., Gilson, W. D., Schär, M., Sosnovik, D. E., Kraitchman, D. L., Boston, R. C., Bulte, J. W. M., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.063 · Cited by 118
Wang, H.-W., Langohr, I. M., Sturek, M. S., & Cheng, J. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.189316 · Cited by 118
Inflammation and atherosclerosis: what is on the horizon?
Ruparelia, N., & Choudhury, R. P. (2019) · Heart · doi:10.1136/heartjnl-2018-314230 · Cited by 123
Uchida, M., Kosuge, H., Terashima, M., Willits, D. A., Liepold, L. O., Young, M., McConnell, M. V., & Douglas, T. (2011) · ACS Nano · doi:10.1021/nn102863y · Cited by 116
Mushenkova, N. V., Summerhill, V. I., Zhang, D., Romanenko, E. B., Grechko, A. V., & Orekhov, A. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082992 · Cited by 122
Lim, R. S., Suhalim, J. L., Miyazaki‐Anzai, S., Miyazaki, M., Levi, M., Potma, E. O., & Tromberg, B. J. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m018077 · Cited by 110
Ta, H. T., Li, Z., Hagemeyer, C. E., Cowin, G., Zhang, S., Palasubramaniam, J., Alt, K., Wang, X., Peter, K., & Whittaker, A. K. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.04.037 · Cited by 109
van Tilborg, G. A. F., Vucic, E., Strijkers, G. J., Cormode, D. P., Mani, V., Skajaa, T., Reutelingsperger, C. P. M., Fayad, Z. A., Mulder, W. J. M., & Nicolay, K. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100091q · Cited by 114
Self-citationMcAteer, M. A., Akhtar, A. M., Mühlen, C. V. Z., & Choudhury, R. P. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.10.009 · Cited by 115
Noninvasive In Vivo Imaging of Monocyte Trafficking to Atherosclerotic Lesions
Kircher, M. F., Grimm, J., Świrski, F. K., Libby, P., Gerszten, R. E., Allport, J. R., & Weissleder, R. (2008) · Circulation · doi:10.1161/circulationaha.107.719765 · Cited by 110
Cormode, D. P., Briley-Saebo, K. C., Mulder, W. J. M., Aguinaldo, J. G. S., Barazza, A., Ma, Y., Fisher, E. A. A., & Fayad, Z. A. (2008) · Small · doi:10.1002/smll.200701285 · Cited by 107
Self-citationA high relaxivity Gd(III)DOTA-DSPE-based liposomal contrast agent for magnetic resonance imaging
Hak, S., Sanders, H. M. H. F., Agrawal, P., Langereis, S., Grüll, H., Keizer, H. M., Arena, F., Terreno, E., Strijkers, G. J., & Nicolay, K. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.017 · Cited by 103
Pathophysiological relevance of macrophage subsets in atherogenesis
Liberale, L., Dallegri, F., Carbone, F., & Montecucco, F. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-08-0593 · Cited by 103
Porous Polymersomes with Encapsulated Gd‐Labeled Dendrimers as Highly Efficient MRI Contrast Agents
Cheng, Z., Thorek, D. L. J., & Tsourkas, A. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200901253 · Cited by 104
Paramagnetic Porous Polymersomes
Cheng, Z., & Tsourkas, A. (2008) · Langmuir · doi:10.1021/la801027q · Cited by 99
Ye, F., Jeong, E., Jia, Z., Yang, T., Parker, D., & Lu, Z. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800211r · Cited by 97
Lipinski, M. J., Frias, J. C., Amirbekian, V., Briley-Saebo, K. C., Mani, V., Samber, D. D., Abbate, A., Aguinaldo, J. G. S., Massey, D. H., Fuster, V., et al. (2009) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2008.08.009 · Cited by 96
Self-citationGadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosis
Maiseyeu, A., Mihai, G., Kampfrath, T., Simonetti, O. P., Sen, C. K., Roy, S., Rajagopalan, S., & Parthasarathy, S. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800405-jlr200 · Cited by 94
Huang, G., Zhang, C., Li, S., Khemtong, C., Yang, S.-G., Tian, R., Minna, J. D., Brown, K. C., & Gao, J. (2009) · Journal of Materials Chemistry · doi:10.1039/b902358e · Cited by 94
Qiao, H., Wang, Y., Zhang, R., Gao, Q., Liang, X. Y., Gao, L., Jiang, Z., Qiao, R., Han, D. H., Zhang, Y., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.011 · Cited by 92
Morris, J. B., Olzinski, A. R., Bernard, R. E., Aravindhan, K., Mirabile, R. C., Boyce, R. W., Willette, R. N., & Jucker, B. M. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.151175 · Cited by 91
Bond‐selective imaging of deep tissue through the optical window between 1600 and 1850 nm
Wang, P., Wang, H., Sturek, M. S., & Cheng, J. (2011) · Journal of Biophotonics · doi:10.1002/jbio.201100102 · Cited by 90
Chen, W., Vucic, E., Leupold, E., Mulder, W. J. M., Cormode, D. P., Briley-Saebo, K. C., Barazza, A., Fisher, E. A. A., Dathe, M., & Fayad, Z. A. (2008) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.257 · Cited by 86
Self-citationYou, D. G., Saravanakumar, G., Son, S., Han, H. S., Heo, R., Kim, K., Kwon, I. C., Lee, J. Y., & Park, J. H. (2013) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2013.10.068 · Cited by 88
Atherosclerosis and Matrix Metalloproteinases: Experimental Molecular MR Imaging in Vivo
Amirbekian, V., Aguinaldo, J. G. S., Amirbekian, S., Hyafil, F., Vucic, E., Sirol, M., Weinreb, D. B., Greneur, S. L., Lancelot, E., Corot, C., et al. (2009) · Radiology · doi:10.1148/radiol.2511080539 · Cited by 86
Self-citationBoekhorst, B. C. M. T., Bovens, S. M., Hellings, W. E., van der Kraak, P. H., van de Kolk, K. W. A., Vink, A., Moll, F. L., van Oosterhout, M. F. M., de Vries, J. P., Doevendans, P. A., et al. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq340 · Cited by 81
Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI
Tarín, C., Carril, M., Martı́n-Ventura, J. L., Markuerkiaga, I., Padró, D., Llamas‐Granda, P., Moreno, J. A., Garcı́a, I., Genicio, N., Plaza‐García, S., et al. (2015) · Scientific Reports · doi:10.1038/srep17135 · Cited by 80
Molecular targeting of atherosclerotic plaques by a stabilin-2-specific peptide ligand
Lee, G. Y., Kim, J.-H., Oh, G. T., Lee, B.-H., Kwon, I. C., & Kim, I. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.010 · Cited by 79
Waters, E. A., & Wickline, S. A. (2008) · Basic Research in Cardiology · doi:10.1007/s00395-008-0711-6 · Cited by 77
Hyaluronic Acid Nanoparticles as Nanomedicine for Treatment of Inflammatory Diseases
Rao, N. V., Rho, J. G., Um, W., Ek, P. K., Nguyen, V. Q., Oh, B. H., Kim, W., & Park, J. H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100931 · Cited by 79
Maiocchi, S. L., Ku, J., Thai, T., Chan, E., Rees, M. D., & Thomas, S. R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107711 · Cited by 78
Lim, R. S., Kratzer, A., Barry, N. P., Miyazaki‐Anzai, S., Miyazaki, M., Mantulin, W. W., Levi, M., Potma, E. O., & Tromberg, B. J. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003616 · Cited by 75
Polymer‐based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis
Lewis, D. R., Kamisoglu, K., York, A. W., & Moghe, P. V. (2011) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.145 · Cited by 74
Inoue, T., Yamashita, Y., Nishihara, M., Sugiyama, S., Sonoda, Y., Kumabe, T., Yokoyama, M., & Tominaga, T. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-068 · Cited by 73
Cormode, D. P., Chandrasekar, R., Delshad, A., Briley-Saebo, K. C., Calcagno, C., Barazza, A., Mulder, W. J. M., Fisher, E. A., & Fayad, Z. A. (2009) · Bioconjugate Chemistry · doi:10.1021/bc800520d · Cited by 72
Self-citationForm to function: current and future roles for atherosclerosis imaging in drug development
Lindsay, A. C., & Choudhury, R. P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2588 · Cited by 72
Macrophage-targeted delivery systems for nucleic acid therapy of inflammatory diseases
Singh, A. K., Talekar, M., Raikar, A., & Amiji, M. M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.021 · Cited by 73
Beckmann, N., Cannet, C., Babin, A. L., Blé, F., Zurbruegg, S., Kneuer, R., & Dousset, V. (2009) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.16 · Cited by 73
Molecular Body Imaging: MR Imaging, CT, and US. Part II. Applications
Kircher, M. F., & Willmann, J. K. (2012) · Radiology · doi:10.1148/radiol.12111703 · Cited by 76
Nanoparticles for Optical Molecular Imaging of Atherosclerosis
Douma, K., Prinzen, L., Slaaf, D. W., Reutelingsperger, C. P. M., Biessen, E. A. L., Hackeng, T. M., Post, M. J., & van Zandvoort, M. A. M. J. (2009) · Small · doi:10.1002/smll.200801079 · Cited by 72
Fractionated feridex and positive contrast: In vivo MR imaging of atherosclerosis
Briley-Saebo, K. C., Mani, V., Hyafil, F., Cornily, J., & Fayad, Z. A. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21541 · Cited by 70
Self-citationMolecular Imaging of Inflammation in Atherosclerosis
Wildgruber, M., Świrski, F. K., & Zernecke, A. (2013) · Theranostics · doi:10.7150/thno.5771 · Cited by 73
Mohs, A. M., & Lu, Z. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.2.149 · Cited by 69
Molecular imaging of macrophage protease activity in cardiovascular inflammation in vivo
Quillard, T., Croce, K., Jaffer, F. A., Weissleder, R., & Libby, P. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-09-0589 · Cited by 67
Nanoparticles as magnetic resonance imaging contrast agents for vascular and cardiac diseases
Chen, W., Cormode, D. P., Fayad, Z. A., & Mulder, W. J. M. (2010) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.114 · Cited by 67
Self-citationNew SPECT and PET Radiopharmaceuticals for Imaging Cardiovascular Disease
Sogbein, O. O., Pelletier‐Galarneau, M., Schindler, T. H., Wei, L., Wells, R. G., & Ruddy, T. D. (2014) · BioMed Research International · doi:10.1155/2014/942960 · Cited by 69
Molecular Imaging of Atherothrombotic Diseases
Wang, X., & Peter, K. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.306483 · Cited by 67
Briley-Saebo, K. C., Crich, S. G., Cormode, D. P., Barazza, A., Mulder, W. J. M., Chen, W., Giovenzana, G. B., Fisher, E. A. A., Aime, S., & Fayad, Z. A. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp8108286 · Cited by 68
Self-citationSegers, F. M., den Adel, B., Bot, I., van der Graaf, L. M., van der Veer, E. P., Gonzalez, W., Raynal, I., de Winther, M. P. J., Wodzig, W. K. W. H., Poelmann, R. E., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300707 · Cited by 66
Yoo, S. P., Pineda, F., Barrett, J. C., Poon, C. J., Tirrell, M., & Chung, E. J. (2016) · ACS Omega · doi:10.1021/acsomega.6b00210 · Cited by 64
Doiron, A. L., Chu, K. S., Ali, A., & Brannon‐Peppas, L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710205105 · Cited by 62
Sirol, M., Moreno, P., Purushothaman, K., Vucic, E., Amirbekian, V., Weinmann, H., Muntner, P., Fuster, V., & Fayad, Z. A. (2009) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.108.801712 · Cited by 61
Self-citationFluorine MR Imaging of Inflammation in Atherosclerotic Plaque in Vivo
van Heeswijk, R. B., Pellegrin, M., Flögel, U., Gonzales, C., Aubert, J.-F., Mazzolai, L., Schwitter, J., & Stuber, M. (2014) · Radiology · doi:10.1148/radiol.14141371 · Cited by 61
The choice of targets and ligands for site-specific delivery of nanomedicine to atherosclerosis
Zia, A., Wu, Y., Nguyen, T. A. H., Wang, X., Peter, K., & Ta, H. T. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa047 · Cited by 60
Metadata
- Authors
- Amirbekian, V., Lipinski, M. J., Briley-Saebo, K. C., Amirbekian, S., Aguinaldo, J. G. S., Weinreb, D. B., Vucic, E., Frias, J. C., Hyafil, F., Mani, V., Fisher, E. A., & Fayad, Z. A.
- Affiliations
- Johns Hopkins University (US)
- Sarnoff Cardiovascular Research Foundation (US)
- Icahn School of Medicine at Mount Sinai (US)
- Emory University (US)
- New York University (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2007-01-16
- Volume
- 104
- Issue
- 3
- Pages
- 961-966
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1766334
- OpenAlex
- W1986805734
- Cited by
- 356
- References
- 35
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 9 · 2021: 4 · 2020: 12 · 2019: 14 · 2018: 7 · 2017: 13 · 2016: 14 · 2015: 23 · 2014: 26 · 2013: 19 · 2012: 38
- FWCI
- 17.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Foundation (9724504, 1 S10 RR0 9145-01)
- Sarnoff Cardiovascular Research Foundation
- National Institutes of Health (1s10rr009145-01, 1S10 RR0 9145-01)
- National Heart, Lung, and Blood Institute (R01HL078667, U01 HL 71021, R01HL071021, U01HL070524)
- National Cancer Institute (R24CA095823)
- National Center for Research Resources (1 S10RR0 9145-01)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- atherosclerosis, macrophages, molecular MRI, macrophage scavenger receptor, targeted contrast agents, non-invasive imaging, atherosclerotic plaque, plaque vulnerability, ApoE-deficient mice, Gd-DTPA, monoclonal antibodies, macrophage content
- MeSH terms
- Animals, Apolipoproteins E, Macrophages, Magnetic Resonance Imaging, Micelles, Microscopy, Confocal, Atherosclerosis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review